We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+8.39%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$11.3B
AUM Growth
+$1.62B
Cap. Flow
+$896M
Cap. Flow %
7.96%
Top 10 Hldgs %
56.76%
Holding
110
New
30
Increased
24
Reduced
18
Closed
25

Top Buys

Rank Stock Value
1
EFX icon
Equifax
EFX
+$171M
2
TWX
Time Warner Inc
TWX
+$146M
3
NXPI icon
NXP Semiconductors
NXPI
+$145M
4
KITE
Kite Pharma, Inc.
KITE
+$136M
5
TRU icon
TransUnion
TRU
+$106M

Top Sells

Rank Stock Value
1
MBLY
Mobileye N.V.
MBLY
+$371M
2
SBAC icon
SBA Communications
SBAC
+$132M
3
TMH
Team Health Holdings Inc
TMH
+$105M
4
ALR
Alere Inc
ALR
+$82.4M
5
META icon
Meta Platforms (Facebook)
META
+$75.8M

Sector Composition

Rank Sector Weight
1 Technology 23.58%
2 Communication Services 19.94%
3 Healthcare 12.5%
4 Industrials 7.48%
5 Financials 3.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QCOM icon
76
Qualcomm
QCOM
$155B
$4.41M 0.04%
85,000
– –
BKD icon
77
Brookdale Senior Living
BKD
$3.49B
$3.5M 0.03%
330,000
– –
VYGR icon
78
Voyager Therapeutics
VYGR
$183M
$3.45M 0.03%
+167,665
New +$1.89M
GCVRZ
79
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$2.46M 0.02%
6,827,805
– –
KALA icon
80
KALA BIO
KALA
$14.1M
$2.28M 0.02%
+40
New +$2.19M
DCPH
81
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$1.9M 0.02%
+100,000
New +$1.83M
NITE
82
DELISTED
Nightstar Therapeutics plc American Depositary Shares
NITE
$774K 0.01%
+40,300
New +$870K
ALNY icon
83
Alnylam Pharmaceuticals
ALNY
$27.5B
– –
-200,000
Closed -$16M
AMRN
84
Amarin Corp
AMRN
$299M
– –
-74,750
Closed -$6.03M
FBRX icon
85
Forte Biosciences
FBRX
$1.57B
– –
-267
Closed -$1.2M
H icon
86
Hyatt Hotels
H
$16.4B
– –
-265,000
Closed -$14.9M
HUM icon
87
Humana
HUM
$43.7B
– –
-178,500
Closed -$43M
PBYI icon
88
Puma Biotechnology
PBYI
$404M
– –
-213,000
Closed -$18.6M
TGNA
89
DELISTED
TEGNA Inc
TGNA
– –
-670,000
Closed -$9.65M
IMGN
90
DELISTED
Immunogen Inc
IMGN
– –
-505,000
Closed -$3.59M
CLVS
91
DELISTED
Clovis Oncology, Inc.
CLVS
– –
-610,000
Closed -$57.1M
IMMU
92
DELISTED
Immunomedics Inc
IMMU
– –
-4,227,500
Closed -$37.3M
PTLA
93
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
– –
-855,000
Closed -$48M
PTLA
94
PUT
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
– –
-250,000
Closed -$14M
AGN
95
DELISTED
Allergan plc
AGN
– –
-227,500
Closed -$55.3M
HZNP
96
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
– –
-745,000
Closed -$8.84M
AKAO
97
DELISTED
Achaogen Inc
AKAO
– –
-948,500
Closed -$20.6M
RXDX
98
DELISTED
Ignyta, Inc.
RXDX
– –
-1,153,500
Closed -$11.9M
CAB
99
DELISTED
Cabela's Inc
CAB
– –
-605,000
Closed -$35.9M
WBMD
100
DELISTED
WebMD Health Corp.
WBMD
– –
-679,130
Closed -$39.8M
1 2 3
4
5

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q3 2017 Portfolio in Review

As of Q3 2017, Farallon Capital Management held 110 positions worth $11.3B, up 17% from $9.63B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Farallon Capital Management deployed $896M of net new capital in Q3 2017, opening 30 new positions and adding to 24 existing holdings. Its largest new stake was Equifax: 1,290,000 shares worth $137M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was SBA Communications, an estimated $132M trimmed.

  • Farallon Capital Management's largest Q3 2017 buy was Equifax: 1,290,000 shares worth $137M.
  • Farallon Capital Management added most to Time Warner Inc in Q3 2017, an estimated $146M increase.
  • Farallon Capital Management's biggest Q3 2017 reduction was SBA Communications, cutting an estimated $132M.
  • Farallon Capital Management fully exited Mobileye N.V. in Q3 2017, selling an estimated $371M.
  • Farallon Capital Management's ten largest holdings make up 57% of its $11.3B portfolio in Q3 2017.
  • Farallon Capital Management opened 30 new positions and closed 25 in Q3 2017.
  • Farallon Capital Management's portfolio value rose 17% quarter-over-quarter to $11.3B.

Based on Farallon Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.